Blood Sugar News and Research

RSS

Blood sugar concentration, or glucose level, refers to the amount of glucose present in the blood of a human or animal. Normally, in mammals the blood glucose level is maintained at a reference range between about 3.6 and 5.8 mM (mmol/l). It is tightly regulated as a part of metabolic homeostasis.

Gestational diabetes cases surge across England, raising health concerns

One in eight mothers in England is now diagnosed with gestational diabetes, with diagnoses rising by 60 per cent in just five years, according to a major study.

3 Aug 2026

Consuming less protein could have greater health benefits and extend lifespan

Protein-fortified foods are popping up everywhere, from cereal and coffee to even protein water. But a new review covering over 350 papers on protein restriction and aging-publishing July 31 in the Cell Press journal Cell Press Blue-suggests that consuming less protein could have greater health benefits and could, in some cases, extend lifespan.

31 Jul 2026

New home test uses thigh length to detect type 2 diabetes or prediabetes

A new home test can detect type 2 diabetes or prediabetes with high accuracy. The test has been developed using artificial intelligence and large amounts of health data – and surprisingly, one of the steps involves measuring the length of your thigh.

29 Jul 2026

Study reveals how gum disease drives systemic inflammation

A recent study revealed that periodontitis reprograms bone marrow neutrophils through a Chac2-driven glutathione metabolic pathway, promoting a highly inflammatory N1 state that fuels systemic inflammation.

28 Jul 2026

Genetic factors influence cholesterol response to low-carb diets

Can a low-carb diet cause your cholesterol to skyrocket? This question has vexed researchers and influencers alike as the popularity of low-carbohydrate diets has surged, yet the evidence has remained mixed.

27 Jul 2026

Cambridge scientists solve brain puzzle behind popular obesity drugs

Cambridge scientists have solved the mystery of why both stimulating and blocking a particular 'switch' in the brain can help people lose weight – findings which could help boost the effectiveness of obesity drugs.

24 Jul 2026

Generic semaglutide could improve diabetes treatment affordability in Canada

In a novel analysis examining the economic implications of generic semaglutide entering the Canadian market, researchers predict that the anticipated price reductions of up to 70% will dramatically increase both the cost-effectiveness and health system affordability of therapy options for patients with type 2 diabetes and high cardiorenal risk.

22 Jul 2026

Medically tailored grocery deliveries improve blood sugar control among diabetes patients

A study from researchers at top US health insurance and medical services provider Kaiser Permanente, the Food is Medicine Institute at the Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy at Tufts University and The George Institute for Global Health found medically tailored grocery deliveries improved blood sugar control among adults living with type 2 diabetes who have public health insurance, when compared with usual care.

21 Jul 2026

Semaglutide fuels rapid growth in US GLP-1RA use as payments rise

Nationally representative US data show GLP-1RA use rose 230% among adults with diabetes and 643% among those without reported diabetes between 2017 and 2022, largely driven by semaglutide. Mean annual out-of-pocket payments decreased, but mean total annual payments per user increased, raising concerns about long-term affordability.

20 Jul 2026

High doses of caffeine from energy drinks cause cardiovascular harm

Previous studies have found that caffeine is the world's most popular stimulant and psychoactive substance, and coffee is the most common way people consume caffeine.

20 Jul 2026

Popular diabetes drugs do not alter the risk of developing a blinding eye condition

An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs) - a type of medication that mimics the GLP-1 hormone - to lower blood sugar and support weight loss. Some research has suggested that their use can reduce the risk of developing other diseases.

17 Jul 2026

Study finds some sweeteners can slow the growth of gut bacteria

Cambridge researchers have shown how commonly-used sweeteners slow the growth of certain gut bacteria.

16 Jul 2026

Sleep patterns influence eating habits and metabolic health

Whether you are an early bird or a night owl, your sleep patterns can tell a lot about a person's eating habits and subsequently the potential health risks.

13 Jul 2026

Muscle health plays crucial role in diabetes risk, study finds

A major new international study led by Curtin University, has found diabetes risk is about more than just body weight or obesity, revealing muscle health also likely plays a big role in whether people will develop the condition.

13 Jul 2026

Study reveals substantial rise in Latin American dementia rates

A new study led by researchers at Washington University School of Medicine in St. Louis and Newcastle University in the U.K. finds that the share of adults living with dementia rose substantially across several Latin American and Caribbean sites over the past two decades.

13 Jul 2026

Silk patch enables painless monitoring of premature babies' health

In the neonatal intensive care unit, the most fragile patients in medicine are often the most heavily wired. Premature babies, some weighing less than a pound, can be tethered to a tangle of cables, monitors, and sensors.

9 Jul 2026

LEAP2 hormone may predict anorexia nervosa relapse risk

People with anorexia nervosa have unusually high levels of a hormone called LEAP2 in their blood when they are in the acute phase of the disorder, according to research presented today (Thursday) at the Federation of European Neuroscience Societies (FENS) Forum 2026.

8 Jul 2026

U.S. obesity rates rose sharply between 1999 and 2023

Obesity rates among U.S. adults and children rose sharply in recent years and by 2023, 40% of adults and 20% of youth met the criteria for obesity, according to new, independent research published today in the American Heart Association's flagship journal Circulation.

7 Jul 2026

Trial supports glargine use in resource-limited Type 1 diabetes care

A trial led by University of Pittsburgh researchers and published today in The Lancet Diabetes & Endocrinology adds nuance to the question of whether older human insulins are as effective as insulin analogues in low-resource settings.

6 Jul 2026

Study tracks why rural residents face higher chronic disease risks

Following the release of data from Assumption Parish earlier this year, researchers at LSU's Pennington Biomedical Research Center have published the first set of data from the Risks Underlying Rural Areas Longitudinal, or RURAL, Heart and Lung study in Franklin Parish. The data book for Franklin Parish is now available to explore.

6 Jul 2026